Plain-English translation of NCT06208462 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination of three treatments — chemotherapy delivered directly to the liver (called HAIC with GEMOX), plus two additional medications called and — given before surgery for people with bile duct cancer that has high-risk features. The goal is to see if giving these medications before surgery can shrink the tumor, reduce the chance it comes back after surgery, and improve overall survival.
Bile duct cancer often comes back after surgery, even when doctors remove all visible tumor. This trial exists to see whether giving strong combination treatment before surgery — rather than after — can help prevent recurrence and improve outcomes for people with this aggressive cancer.
You likely qualify if…
You likely don't qualify if…
You would receive up to 4 rounds of combination treatment before surgery, with each round lasting 3 weeks. During each round, you receive chemotherapy injected into the liver blood vessel, plus two medications by IV and by mouth. Your tumor is evaluated every 2 rounds. About 1 month after finishing treatment, you undergo surgery to remove the cancer. After surgery, you take an oral chemotherapy medication for 2 weeks. The entire process takes roughly 3–4 months from start to finish.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
China